Drilldown: Medicines

None · Codeine · 1,4-Butanediol · 1B-LSD · 1cP-LSD · 1P-LSD · 1V-LSD · 2-AI · 2-FA · 2-FDCK · 2-FMA · 25B-NBOH · 25B-NBOMe · 25C-NBOH · 25C-NBOMe · 25I-NBOH · 25I-NBOMe · 25N-NBOMe · 2C-B · 2C-B-FLY

Other values:

Search

None (2) · (multiple, generic dominant) (1) · Inderal (1)

Analgesic (2) · Beta Blocker (1) · GABAergic (1) · Non-selective (1) · Opioid (2) · Prodrug (1) · Research material (1)

Mu-opioid receptor agonist; prodrug (metabolized to morphine) (1) · Non-selective competitive antagonist at β1 and β2 adrenergic receptors. Lipophilic; significant blood–brain barrier penetration, accounting for its CNS effects. (1) · Prodrug of GHB (1) · Prodrug; converted to [[Morphine|morphine]] by [[Enzyme:CYP2D6|CYP2D6]] for analgesic action. (1)

None (2) · Mild to moderate pain; cough suppression (low-dose). (1) · '"`UNIQ--vote-000005E7-QINU`"', '"`UNIQ--vote-000005E8-QINU`"', '"`UNIQ--vote-000005E9-QINU`"', '"`UNIQ--vote-000005EA-QINU`"', '"`UNIQ--vote-000005EB-QINU`"' (1)

None (2) · 10–40 mg (situational anxiety); 40 mg BID (HTN) (1) · Adult: 15–60 mg every 4 hours as needed. (1)

None (2) · 10, 20, 40, 60, 80 mg tabs; 60/80/120/160 mg ER caps; 1 mg/mL IV (1) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)

None (2) · 360 mg/day (1) · 640 mg/d (HTN); 240 mg/d (migraine) (1)

None (2) · IV (1) · Oral (1) · PO (only formulation marketed in the US). (1)

None (2) · 1–2 h (PO), immediate (IV) (1) · 30–60 min (PO) (1)

None (2) · 4–6 hours (1) · 6–12 h (IR); 24 h (ER) (1)

None (2) · 2.5–3 hours (1) · 3–6 h (1)

None (2) · ~25% (extensive hepatic first-pass) (1) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1)

None (2) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1) · Category C (1)

None (2) · Rx-only in US (1) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1)